Dr. Dima Abdelmannan, is an Associate Professor and Vice Clinical Dean of Dubai Medical College in Dubai, U.A.E. Dr. Dima Abdelmannan is also a Consultant Endocrinologist at the Dubai Diabetes Center at Dubai Health Authority. Dr. AbdelMannan has dual boards from both the UK and the USA. In the United States she completed her internal medicine residency training from the Cleveland Clinic Health System and then completed fellowship training in Endocrinology, Diabetes and Metabolism at Case Western Reserve University, in Cleveland, OH. She continued to do clinical and Research work at the same institution for several years before returning to Dubai, UAE to hold an academic position. Her research work is in the fields of Pituitary and adrenal diseases as well as Diabetes. She has presented her work at national American meetings and published it in peer-reviewed journals. Besides being interested in Clinical Endocrinology and research she has been interested in Medical Education and therefore took this leading role at the medical school in order to help improve the standards of medical education in Dubai and the UAE. Dr. Abdelmannan is a scholar of the Harvard Macy Institute of Health professionals as educators and is actively involved in implementing efficient ways in medical pedagogy including simulation and e-learning.

James W. Findling, MD, FACP is Professor of Medicine and Director of the Endocrine Center and Clinics at the Medical College of Wisconsin. He is a graduate of the University of Notre Dame and Northwestern University Medical School. He completed his internal medicine training at the Medical College of Wisconsin and his post-doctoral fellowship in Endocrinology and Metabolism at the University of California-San Francisco. He started his endocrinology practice at St. Luke's Medical Center in Milwaukee in 1982 and he started the Endocrine-Diabetes Center at St. Luke's in 1987. Dr. Findling joined the full-time faculty of the Medical College of Wisconsin in 2008. He has over 100 publications and book chapters and is considered an international expert on clinical disorders of pituitary and adrenal function. He has served as visiting professor at many institutions including the Mayo Clinic, Massachusetts General Hospital, Johns Hopkins, University of Iowa, University of Kansas, University of Texas-Southwestern, University of Colorado, University of Nebraska, University of Pittsburgh, and the Cleveland Clinic.

Prof. Hossein Gharib received a B.S. degree from the Ohio State University in 1962. He went on to receive a medical degree from the University of Michigan Medical School in 1966, and took his internship at Philadelphia General Hospital from 1966 to 1967. He completed an internal medicine residency (1967–1969) and fellowship in endocrinology and metabolism (1969–1971) at the Mayo Clinic in Rochester, Minnesota. After a visiting fellowship in reproductive endocrinology at the Columbia University College of Physicians & Surgeons in New York City, he joined the Mayo Clinic faculty in Rochester in 1972. In 1974, he went back briefly to Iran where he served on the faculties of the University of Tehran and the National University Medical Schools. During his tenure in Iran, he was initially a consultant at the Queen Heart Hospital before he was appointed the Medical Director of the Reza Pahlavi Medical Center (1975–1977). Dr. Gharib later became the Associate Dean of the College of Health Sciences (1977) and served as the director of the Department of Internal Medicine at Saadat-Abad Medical Center, National University (1977–1979). In June 1979, he returned to the Mayo Clinic in Rochester where he is now Professor of Medicine at the Mayo Clinic College of Medicine, and a consultant in the Division of Endocrinology, Metabolism, and Nutrition. He also teaches medical residents and endocrine fellows, and conducts clinical research. Dr. Hossein Gharib has become an internationally-known authority on thyroid disorders.

George Grunberger, MD, FACP, FACE is the Chairman of Grunberger Diabetes Institute (GDI) in Bloomfield Hills, Michigan. Dr. Grunberger is also Clinical Professor of Internal Medicine and of Molecular Medicine & Genetics at Wayne State University School of Medicine (Detroit, MI), Professor of Internal Medicine at Oakland University William Beaumont School of Medicine (Rochester, MI) as well as Visiting Professor in the First Faculty of Medicine at Charles University in Prague (Czech Republic).

Before forming GDI in 2002, Dr. Grunberger established and directed for 16 years the Diabetes Program at the Detroit Medical Center and Wayne State University’s Comprehensive Diabetes Center. Between 1986 and 2002. Dr. Grunberger was tenured Full Professor of Internal Medicine and of Molecular Medicine and Genetics. Dr. Grunberger came to Detroit from the Diabetes Branch of NIDDK/NIH in Bethesda, MD where he trained in endocrinology/metabolism and then worked there as a basic and clinical researcher for six years. Dr. Grunberger received his internal medicine training at the University Hospitals of Cleveland at Case Western Reserve University, his medical (M.D.) training at the New York University School of Medicine and his bachelor’s degree (in biochemistry) at Columbia College of Columbia University, also in New York City.

Dr. Grunberger’s clinical and basic research endeavors have been well recognized. He has published well over hundred original peer-reviewed manuscripts, in addition to review articles, abstracts, book chapters, and letters to journals. His research interests have spanned the spectrum of subjects related to diabetes and its complications, from basic studies on molecular underpinning of insulin action and insulin resistance to clinical research studies on many aspects of diabetes and its management. He has trained a generation of young basic and clinical research investigators. He is currently a co-editor of two international diabetes journals.

Dr. Grunberger has been active in several professional societies (American Diabetes Association, American Association of Clinical Endocrinologists, The Endocrine Society, European Associations for Study of Diabetes, etc.) where he has held elected positions of leadership. He now serves as President of AACE.

Amir H. Hamrahian, MD, is Chief of Endocrinology in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi. He specializes in Endocrinology, Diabetes, and Metabolism.

Prior to joining Cleveland Clinic Abu Dhabi, Dr. Hamrahian served as the Director of Clinical Research at the Endocrinology and Metabolism Institute, and the Director of the Endocrinology Fellowship Program at US-based Cleveland Clinic.

He specializes in Endocrinology, Diabetes, and Metabolism and has special interests in pituitary and adrenal disorders. Dr. Hamrahian has published more than 65 peer reviewed articles, along with more than 70 abstracts and book chapters. He has given presentations on pituitary and adrenal disorders at national meetings of the Endocrine Society and the American Association of Clinical Endocrinologists (AACE) annual meetings. He served as co-author on AACE adrenal incidentaloma, cushing and acromegaly guidelines, and has participated in the international consensus conferences on diagnosis and management of acromegaly. He has served as the principal investigator for a number of pituitary-related clinical research studies. He initiated and co-directed an annual Pituitary Day Conference in Cleveland from 2005 to 2014.

Dr. Hamrahian received his medical degree from Hacettepe University in Ankara, Turkey. He completed his Internal Medicine residency at the University of North Dakota in Fargo, North Dakota and his fellowship in Endocrinology at Case Western Reserve University in Cleveland, Ohio.

Dr. Richard Mack Harrell, MD, FACP, FACE, ECNU received his Bachelor’s and Medical Degrees from the University of North Carolina at Chapel Hill, where he was awarded the prestigious Morehead Fellowship in Medicine. After completing a residency in Internal Medicine at the University of Minnesota, Dr. Harrell did a clinical and research fellowship in Endocrinology at Duke University. As a faculty member, he developed a special interest in parathyroid, thyroid and adrenal disease.

In 1991, Dr. Harrell was recruited by Cleveland Clinic Florida, where he pioneered office neck ultrasonography and became their first Chief of Endocrinology, before moving on to become the Director of Metabolic Outcomes for the North Broward Hospital District in Ft. Lauderdale in 1999. He began an endocrine surgical collaboration with David Bimston, MD, in 2005, before both specialists moved their practice to the Memorial Healthcare System in 2011. Dr. Harrell has been recognized with “Patients’ Choice” and “Top Doctor” awards.

Dr. Harrell is board certified in Endocrinology and Metabolism by the American Board of Internal Medicine. In addition, he is among fewer than 200 physicians worldwide who have completed the Endocrine Neck Ultrasound (ECNU) program administered by the American Association of Clinical Endocrinology (AACE), where he serves on the Executive Committee. Dr. Harrell has served as a Clinical Professor of Medicine at Nova Southeastern University since 2001. During more than 20 years in Neck Ultrasonography practice and more than 26 years in Endocrinology consultation work, Dr. Harrell has performed thousands of thyroid biopsies and parathyroid localizations. He brings a unique expertise to the diagnosis and treatment of thyroid, parathyroid and adrenal tumors.

Dr. Frances J. Hayes is a Staff Endocrinologist in Reproductive Endocrine Associates at the Massachusetts General Hospital, an Assistant Professor of Medicine at Harvard Medical School, Clinical Director of the Reproductive Endocrine Unit Reference Laboratory, and the principal investigator on an NIH-funded RO1 grant.

Dr. Hayes’ area of expertise is human reproductive physiology, a topic on which she has published widely. Her research interests include the neuroendocrine regulation of fertility in men, androgen replacement therapy and the relationship between testosterone and insulin resistance in men. She was recently part of a panel of experts convened by the Endocrine Society to provide guidelines for androgen replacement in older men. To date, her research studies have shown that insulin resistance is associated with a decrease in the secretion of testosterone from the testes in men. She is currently examining the impact of short-term medical castration on insulin sensitivity in normal healthy volunteers as well as the impact of testosterone supplementation in men with the metabolic syndrome. Given the significant cardiovascular morbidity and mortality associated with obesity and type 2 diabetes, a clearer understanding of the interplay between testosterone and insulin resistance has important public health implications and may facilitate the development of new therapies for these very common disorders.

Her clinical practice covers the spectrum of reproductive endocrinology including polycystic ovary syndrome, infertility, and male and female hormone replacement therapy for hypogonadism. She coordinates the NIH-sponsored program of long-term pulsatile GnRH administration for men with congenital GnRH deficiency, a therapy that is currently limited to a few academic centers in the United States. In addition, she has expertise in ovulation induction with clomiphene, gonadotropins and pulsatile GnRH for women with idiopathic or anovulatory infertility.

Prior to joining Cleveland Clinic Abu Dhabi, Dr. Hijazi ran a large general endocrinology practice in Tennessee, US, focused on the management of adult diabetes using the latest technologies, such as insulin pumps and continuous glucose sensors. He also served as Head of the Section of Endocrinology, Diabetes, and Metabolism at Cumberland Medical Center in Crossville, Tennessee, US, and was actively involved in teaching medical students.

Dr. Hijazi received his medical degree from the American University of Beirut in Beirut, Lebanon, and completed his residency in Internal Medicine at the University of Connecticut in Farmington, Connecticut, US. He received his fellowship in Endocrinology, Diabetes, and Metabolism from the Baylor College of Medicine and University of Texas MD Anderson Cancer Center in Houston, Texas, US.

Graham T. McMahon M.D. M.M.Sc. is the President and CEO at the Accreditation Council for Continuing Medical Education based in Chicago. Previously he was an Associate Dean and Associate Professor of Medicine at Harvard Medical School, and Program Director for the fellowship program in the Division of Endocrinology, Diabetes and Hypertension at the Brigham & Women’s Hospital in Boston where he completed his postgraduate training. Dr. McMahon received his medical education at the Royal College of Surgeons in Ireland, a master’s degree in clinical research from Harvard Medical School, and his doctorate in education from the National University of Ireland. He was the editor for medical education at the New England Journal of Medicine for more than 10 years. He has received local and national awards for his teaching and his work in medical education and diabetes research. His work has been published in the New England Journal of Medicine, Diabetes Care, the Archives of Internal Medicine, the Journal of General Internal Medicine, and Medical Education.

Dr. Saadi earned his medical degree from the American University of Beirut in 1985. He subsequently trained in Internal Medicine and Endocrinology at Case Western Reserve University in Cleveland, Ohio. Dr. Saadi is a former member of the Cleveland Clinic staff in the Departments of General Internal Medicine and Endocrinology.

Dr. Saadi is a Diplomat of the American Board of Internal Medicine and the American Board of Endocrinology, Diabetes and Metabolism. He is also a fellow of the American College of Physicians and the American Association of Clinical Endocrinologists. His specialty interests include diabetes mellitus, vitamin D deficiency, osteoporosis and general endocrinology. Dr. Saadi has over 100 publications including peer-reviewed articles, abstracts, letters, and chapters and has presented his work at several international meetings. He is a recipient of several awards for his distinguished performance in Research, Education and Clinical service. After serving as Professor and Chairman of the Department of Internal Medicine at the Faculty of Medicine and Health Sciences, United Arab Emirates University, Dr. Saadi rejoined Cleveland Clinic in 2011 as Chief of the Medical Subspecialties Institute of Cleveland Clinic Abu Dhabi. He was also appointed as Clinical Professor of Medicine at Cleveland Clinic in Sep 2012. Dr. Saadi currently practices part time at the Imperial College London Diabetes Center in Abu Dhabi.

Dr. Al-Sayed graduated from Arabian Gulf University, college of Medicine in Bahrain. She completed her Residency training in Internal medicine at Sinai-Grace Hospital, Wayne State University, Detroit, Michigan, USA and Fellowship training in Endocrinology and Diabetes at Cleveland Clinic Foundation, Ohio, USA. Dr. Al-Sayed is also American Board Certified in Clinical Lipidology and a fellow of American College of Physicians. She has worked as assistant professor at Arabian Gulf University and is currently the Medical Director at Gulf Diabetes Specialist Center in Bahrain. Dr. Al-Sayed is a member of the National Lipid Association and other Diabetes and Endocrine Associations and has several research publications. She is a member of Board of Directors of the American Association of Clinical Endocrinologist, Gulf Chapter and a member of expert panel for Middle East Group for Familial Hypercholesterolemia. Dr. Al-Sayed has a special interest in Lipid disorders, diabetes, thyroid, parathyroid, and pituitary disorders.

Robert S. Zimmerman, M.D. is the Vice Chairman Endocrinology Cleveland Clinic and Director of the Diabetes Center in the Department of Endocrinology, Diabetes & Metabolism. He is on the Board of Directors of the American Association of Clinical Endocrinology and is co-chairman of the Endocrinology Board Review Course Committee for the American Association of Clinical Endocrinology. He is currently on the CME committee of the Endocrine Society. He previously served as a member of the Meeting Steering Committee of the Endocrine Society for six years, Governmental Affairs Committee for three years, and the Clinical Affairs Committee for six years.

He is on the Board of the Diabetes Partnership of Cleveland. Previously, he was director of the Ochsner Diabetes Institute and Medical Director of the Division of Nutrition at the Ochsner Clinic in New Orleans, Louisiana. Dr. Zimmerman received his medical degree from the Johns Hopkins University Medical School in Baltimore, Maryland. He served an internship and residency in internal medicine at Duke University Hospital in Durham, North Carolina. He then completed a fellowship in endocrinology and metabolism at the Mayo Clinic in Rochester, Minnesota.

Dr. Zimmerman’s research interests include stress and hypertension, thyroid disease and metabolic abnormalities. He has authored and co-authored more than 100 journal articles, book chapters and abstracts. Dr. Zimmerman is a fellow of the American Association of Clinical Endocrinology and a member of the American Diabetes Association and Endocrine Society.